Stock Scorecard
Stock Summary for Mirum Pharmaceuticals Inc (MIRM) - $45.24 as of 5/8/2025 8:43:10 PM EST
Total Score
6 out of 30
Safety Score
45 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for MIRM
| Positive earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for MIRM
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for MIRM
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for MIRM
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for MIRM (45 out of 100)
| Stock Price Rating (Max of 10) | 8 |
| Historical Stock Price Rating (Max of 10) | 6 |
| Stock Price Trend (Max of 10) | 10 |
| Book Value (Max of 10) | 3 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 5 |
| Analyst Strong Buy Ratings (Max of 5) | 4 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 0 |
| Trading Volume (Max of 10) | 9 |
| Price to Earnings (Max of 10) | 0 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for MIRM
Financial Details for MIRM
Company Overview |
|
|---|---|
| Ticker | MIRM |
| Company Name | Mirum Pharmaceuticals Inc |
| Country | USA |
| Description | Mirum Pharmaceuticals, Inc., a biopharmaceutical company, is focused on the development and commercialization of an advanced line of novel therapies for debilitating liver diseases. The company is headquartered in Foster City, California. |
| Sector Name | LIFE SCIENCES |
| Industry Name | PHARMACEUTICAL PREPARATIONS |
| Most Recent Quarter | 12/31/2024 |
| Next Earnings Date | N/A |
Stock Price History |
|
| Last Day Price | 45.24 |
| Price 4 Years Ago | 15.95 |
| Last Day Price Updated | 5/8/2025 8:43:10 PM EST |
| Last Day Volume | 1,249,638 |
| Average Daily Volume | 458,112 |
| 52-Week High | 54.23 |
| 52-Week Low | 23.83 |
| Last Price to 52 Week Low | 89.84% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 30.37 |
| Sector PE | 45.26 |
| 5-Year Average PE | -7.44 |
| Free Cash Flow Ratio | 10.05 |
| Industry Free Cash Flow Ratio | 18.71 |
| Sector Free Cash Flow Ratio | 29.93 |
| Current Ratio Most Recent Quarter | 3.10 |
| Total Cash Per Share | 4.50 |
| Book Value Per Share Most Recent Quarter | 4.67 |
| Price to Book Ratio | 9.68 |
| Industry Price to Book Ratio | 7.62 |
| Sector Price to Book Ratio | 21.41 |
| Price to Sales Ratio Twelve Trailing Months | 6.48 |
| Industry Price to Sales Ratio Twelve Trailing Months | 89.49 |
| Sector Price to Sales Ratio Twelve Trailing Months | 25.24 |
| Analyst Buy Ratings | 6 |
| Analyst Strong Buy Ratings | 4 |
Share Statistics |
|
| Total Shares Outstanding | 49,454,300 |
| Market Capitalization | 2,237,312,532 |
| Institutional Ownership | N/A |
Dividends |
|
| Ex-Dividend Date | N/A |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.0000 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.00% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 0.00% |
| Annual Earnings Growth | 46.18% |
| Reported EPS 12 Trailing Months | -1.85 |
| Reported EPS Past Year | 0.00 |
| Reported EPS Prior Year | -1.85 |
| Net Income Twelve Trailing Months | -87,942,000 |
| Net Income Past Year | -87,942,000 |
| Net Income Prior Year | -163,415,000 |
| Quarterly Revenue Growth YOY | 42.90% |
| 5-Year Revenue Growth | 0.00% |
| Operating Margin Twelve Trailing Months | -24.40% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 222,503,000 |
| Total Cash Past Year | 222,503,000 |
| Total Cash Prior Year | 286,326,000 |
| Net Cash Position Most Recent Quarter | -85,579,000 |
| Net Cash Position Past Year | -85,579,000 |
| Long Term Debt Past Year | 308,082,000 |
| Long Term Debt Prior Year | 306,421,000 |
| Total Debt Most Recent Quarter | 308,082,000 |
| Equity to Debt Ratio Past Year | 0.42 |
| Equity to Debt Ratio Most Recent Quarter | 0.42 |
| Total Stockholder Equity Past Year | 225,640,000 |
| Total Stockholder Equity Prior Year | 248,670,000 |
| Total Stockholder Equity Most Recent Quarter | 225,640,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | -668,000 |
| Free Cash Flow Per Share Twelve Trailing Months | -0.01 |
| Free Cash Flow Past Year | 9,332,000 |
| Free Cash Flow Prior Year | -91,053,000 |
Options |
|
| Put/Call Ratio | 0.03 |
| Has Options | Options Chain |
| Liquidity Rating | None |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | -0.72 |
| MACD Signal | -1.36 |
| 20-Day Bollinger Lower Band | 37.22 |
| 20-Day Bollinger Middle Band | 44.87 |
| 20-Day Bollinger Upper Band | 52.52 |
| Beta | 0.96 |
| RSI | 56.54 |
| 50-Day SMA | 40.49 |
| 150-Day SMA | 30.38 |
| 200-Day SMA | 27.52 |
System |
|
| Modified | 5/8/2025 5:03:00 AM EST |